Chronic Lymphocytic Leukaemia

CLL Lenalidomide Maintanence 002 - The Continuum Trial

A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF THE EFFICACY AND SAFETY OF LENALIDOMIDE (REVLIMID®) AS MAINTENANCE THERAPY FOR PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA FOLLOWING SECOND-LINE THERAPY (The Continuum Trial)

CLL210 (OfaDexRev)

A Phase II Trial of Ofatumumab, Dexamethasone and Lenalidomide Followed by Randomisation to Lenalidomide Maintenance Versus No Further Treatment for High-Risk CLL.

RIALTO

RIAltO: A Randomised Investigation of Alternative Ofatumumabcontaining regimens in less fit patients with CLL

COSMIC

Combination FC plus Ofatumumab at Standard or Mega dose In CLL

 

GALACTIC

 

GA-101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL

Gilead 133

 

 A Phase 2, Single Arm Study Evaluating the Efficacy and Safety of Idelalisib in Combination with Rituximab in Patients with Previously Untreated Chronic Lymphocytic Leukemia with 17p Deletion